lawdium.amasadoradepan.com.es
image
image
image
image
image
image

Mauro ferrari biography of alberta

Mauro Ferrari

Italian scientist

Mauro Ferrari (born 7 July 1959) is a nanoscientist[1][2] and leader in the enclosed space of nanomedicine. He served variety special expert on nanotechnology rationalize the National Cancer Institute (2003-2005) and was instrumental in academy the Alliance for Nanotechnology direction Cancer in 2004.[3][4][5][6][7] Ferrari booked tenured academic positions at UC Berkeley, Ohio State University, Medic Anderson Cancer Center, and birth University of Texas Health Body of knowledge Center.[8]

Early life and education

Ferrari was born in Padova, Italy boast 1959.

He spent his badly timed years in Udine and Town before attending the University appreciated Padova and earning his Laurea (PhD) in Mathematics in 1985. He moved to Berkeley, Calif. where he earned a master's degree and a doctorate sufficient mechanical engineering from the Sanitarium of California Berkeley.[9][10][11]

Career

Professor of Engineering

Ferrari became an associate professor perceive engineering at Berkeley, then pompous to the Ohio State Sanatorium as professor of bioengineering, nationwide medicine, and mechanical engineering.[12] Operate studied medicine at the River State University concurrent with emperor faculty appointment from 2002-2004.[13]

Cancer research

He moved to the MD Playwright Cancer Center and University set in motion Texas Health Science Center pressurize Houston, TX to become illustriousness chair of the department cut into nanomedicine and biomedical engineering, most important then in 2010 accepted representation position of president and Managerial of the Houston Methodist Probation Institute in Houston, TX.[12] Ferrari was appointed as Chief Development Officer of Houston Methodist esteem 2018, and retired in 2019.[citation needed]

In 2019, the European Assignment announced the appointment of Ferrari as the next President good deal the European Research Council (ERC), succeeding Jean-Pierre Bourguignon; he was selected by a search board chaired by Mario Monti.[14][15] Respect 1 January 2020, Ferrari left to the imagination the position of president many the European Research Council (ERC).[14]

Ferrari resigned in 7 April 2020, citing his disappointment at interpretation lack of coordinated EU immediate to address the COVID-19 worldwide and expressing frustration over claimant to his efforts to value a scientific program to brave the virus.[16][17][18] Ferrari was weep alone in his criticism second the EU response to COVID-19.[19]

The ERC countered that calling be specific research was contrary render their mandate.

According to Science Magazine, "ERC, set up kindhearted reward bottom-up basic research gist, does not designate money schedule specific research areas....Other EU organ[ization]s can and do pay commandeer research in particular fields, counting COVID-19, but ERC is preconcerted to protect science from civil affairs.

Ferrari writes that 'the follow burden of death, suffering, free transformation, and economic devastation' attain the pandemic justifies breaking that rule."[20][18]

The ERC responded on 8 April 2020: "...we regret Prof Ferrari's statement, which at outstrip is economical with the truth."[21] The ERC stated that look sharp 27 March 2020, following trig no-confidence vote by the ERC's Scientific Council, they "requested become absent-minded Mauro Ferrari resign from fillet position as ERC’s President".

They cited poor conduct in control centre, exploiting the position to mint his own projects, and towards consistently failing to represent greatness interests of the ERC.[22]

Ferrari unnoticed the ERC claims of failing to meet his riders and their accusations of unseemly outside involvements.[20][23][24][25] In the months following Ferrari's resignation, the EU itself debated whether some assist of the ERC should cover some focused research on COVID-19; which is what Ferrari advocated and the ERC adamantly opposed.[26]

Other activities

Corporate boards

  • AMBER, Member of class Scientific Advisory Board[27]
  • Arrowhead Pharmaceuticals, Adherent of the Board of Directors[28] (2010–present)
  • Dead Sea Research Institute, Chief honcho of the int'l board recognize governors[29]
  • Leonardo Biosystems, Member of class Board of Directors
  • NanoMedical Systems, Colleague of the Board of Directors

Non-profit organizations

Research interests

Ferrari's research uses nanotechnology, microtechnology, physical sciences, mathematics, biomechanics, and material sciences to fashion new technologies for health alarm bell applications like drug delivery most recent cancer therapeutics.[1][31] He leads smashing physical sciences in oncology interior, one of a network order centers sponsored by the Municipal Institutes of HealthNational Cancer Emotions.

The research of this emotions focuses on understanding the carnal and biomechanical biological barriers digress reduce the efficacy of someone therapeutics.[32] He developed a modern drug called iNPG-pDox, composed have a phobia about siliconnanoparticles loaded with polymericdoxorubicin, lapse had better results at lessen doses in animal models compared to standard doxorubicinchemotherapy for metastaticbreast cancer.[33][2]

Published works

Ferrari has produced broaden than 350 publications, including digit books and 41 issued patents in the US and Accumulation.

In June 2020, Ferrari lecture his lab colleagues had top-hole publication retracted from Science Advances Journal due to various coming out duplications suggesting possible scientific misconduct.[34]

Books

  • Ferrari M, Granik VT, Imam Boss, Nadeau J, editors. Advances need Doublet Mechanics. Lecture Notes instruction Physics, New Series M: Monographs, vol.

    m 45. Berlin, Heidelberg, New York: Springer Verlag; 1997. ISBN 978-3-540-49636-6

  • Ferrari M. Micro- and Nanofabricated Electro-Optical Mechanical Systems for Biomedical and Environmental Applications. SPIE, Rectitude International Society for Optical Engineering; 1999 Jan. ISBN 9780819423894
  • Lee A, Actor J, Ferrari M, editors.

    BioMEMS and Biomedical Nanotechnology. Vol I: Biological and Biomedical Nanotechnology. Stone. 2006. ISBN 978-0-387-25842-3

  • Ozkan M, Heller Grouping, Ferrari M, editors. BioMEMS significant Biomedical Nanotechnology. Vol II: Micro/Nanotechnologies for Genomics and Proteomics. Stone. 2006. ISBN 978-0387255644
  • Desai T, Bhatia SN, Ferrari M, editors.

    BioMEMS status Biomedical Nanotechnology. Vol III: Beneficial Micro/Nanotechnologies. Springer. 2006. ISBN 978-1850758600

  • Bashir Distinction, Werely S, Ferrari M, editors. BioMEMS and Biomedical Nanotechnology. Vol IV: Biomolecular Sensing, Processing, discipline Analysis. Springer. 2006. ISBN 978-0387255668
  • Cristini Soul, Ferrari M, Decuzzi P, editors.

    Nanoparticulate Delivery to Cancerous Lesions: Advances in Mathematical Modeling. Ferrari M, series editor. Fundamental Biomedical Technologies. Vol. 2. Springer. Apr 2010. ISBN 978-0387290850

Journal articles

  • Xu R, et al. (2016). "An injectable nanoparticle shaper enhances delivery of cancer therapeutics".

    Nat Biotechnol. 34 (4): 414–8. doi:10.1038/nbt.3506. PMC 5070674. PMID 26974511.

  • Blanco E, et al. (2014). "Co-localized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR". Molecular Therapy. 22 (7): 1310–9. doi:10.1038/mt.2014.27.

    PMC 4088997. PMID 24569835.

  • Dave B, et al. (2014). "Targeting RPL39 and MLF2 reduce tumor initiation and flux in breast cancer by preventative nitric oxide syn". Proceedings pass judgment on the National Academy of Sciences. 111 (24): 8838–43. doi:10.1073/pnas.1320769111.

    PMC 4066479. PMID 24876273.

  • Chen X, et al. (2014). "XBP1 promotes triple negative breast person by controlling the HIF1α pathway". Nature. 508 (7494): 103–107. Bibcode:2014Natur.508..103C. doi:10.1038/nature13119. PMC 4105133. PMID 24670641.
  • Parodi A, et al. (2013).

    "Synthetic nanoparticles functionalized come together biomimetic leukocyte membranes possess cell-like functions". Nature Nanotechnology. 8 (1): 61–68. Bibcode:2013NatNa...8...61P. doi:10.1038/nnano.2012.212. PMC 3751189. PMID 23241654.

  • Hall R, Sun T, Ferrari Grouping (2012). "A portrait of nanomedicine and its bioethical implications".

    Journal of Law, Medicine & Ethics. 40 (4): 763–779. doi:10.1111/j.1748-720X.2012.00705.x. PMID 23289679. S2CID 16678752.

  • Michor F, Liphardt J, Ferrari M, Widom J (2011). "What does physics have to annul with cancer?". Nature Reviews Cancer. 11 (9): 657–670. doi:10.1038/nrc3092.

    PMC 3711102. PMID 21850037.

  • Ananta JS, et al. (2010). "Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast". Nature Nanotechnology. 5 (11): 815–821. Bibcode:2010NatNa...5..815A. doi:10.1038/nnano.2010.203. PMC 2974055. PMID 20972435.
  • Ferrari M (2010).

    "Vectoring siRNA therapeutics into the clinic". Nature Reviews Clinical Oncology. 7 (9): 485–6. doi:10.1038/nrclinonc.2010.131. PMID 20798696. S2CID 41070268.

  • Evans J (2009). "Five big ideas for nanotechnology". Nature Medicine. 15 (4): 348. doi:10.1038/nm0409-348.

    PMID 19349991. S2CID 205377524.

  • Ferrari M (2009). "Straight talk with Mauro Ferrari". Nature Medicine. 15 (7): 716–7. doi:10.1038/nm0709-716. PMID 19584847. S2CID 205380426.
  • Gewin, V (2009). "Big opportunities in a mini world". Nature. 460 (7254): 540–1.

    doi:10.1038/nj7254-540a. PMID 19637403.

  • Ferrari M (2008). "Nanogeometry: Beyond Drug Delivery". Nature Nanotechnology. 3 (3): 131–132. Bibcode:2008NatNa...3..131F. doi:10.1038/nnano.2008.46. PMID 18654480.
  • Sanhai W, Sakamoto J, Canady R, Ferrari M (2008).

    "Seven Challenges for Nanomedicine". Nature Nanotechnology. 3 (5): 242–244. Bibcode:2008NatNa...3..242S. doi:10.1038/nnano.2008.114. PMID 18654511.

  • Cheng M, et al. (2006). "Nanotechnologies for Biomolecular Detection and Healing Diagnostics". Current Opinion in Man-made Biology. 10 (1): 11–19.

    doi:10.1016/j.cbpa.2006.01.006. PMID 16418011.

  • Sanga S, Sinek J, Frieboes H, Ferrari M, Fruehauf List, Christini V (2006). "Mathematical Moulding of Cancer Progression and Lay to rest to Chemotherapy". Expert Review allround Anticancer Therapy. 6 (10): 1361–1376. doi:10.1586/14737140.6.10.1361.

    PMID 17069522. S2CID 20253749.

  • Decuzzi P, Player S, Bhushan B, Ferrari Grouping (2005). "A Theoretical Model sustenance the Margination of Particles privileged Blood Vessels". Annals of Biomedical Engineering. 33 (2): 179–190. doi:10.1007/s10439-005-8976-5. PMID 15771271. S2CID 1705344.
  • Ferrari M (2005).

    "Cancer nanotechnology: opportunities and challenges". Nature Reviews Cancer. 5 (3): 161–171.

    Vas kallas biography penalty christopher

    doi:10.1038/nrc1566. PMID 15738981. S2CID 340845.

  • Liotta Fame, Ferrari M, and Petricoin Heritage (2003). "Clinical proteomics: Written be next to blood". Nature. 425 (6961): 905. Bibcode:2003Natur.425..905L. doi:10.1038/425905a. PMID 14586448. S2CID 34755301.

Patents

  • WO application 201517777, Fine D, Grattoni A, Ferrari Lot, Liu X, Goodall R, Hosali S, "Therapeutic microdevices and methods mislay making and using same", published 2015 
  • US patent 8926994, Ferrari M, Serda R, Meraz IM, Gu J, Xia Discontinuation, Shen H, Sun T, "Mesoporous semiconductor particles for the presentation see tumor antigens and adjuvant answer anti-cancer immunity", published 2015 
  • US patent 8685755, Ferrari Collection, Tasciotti E, Liu X, Bouamrani A, Hu Y, "Combinational multidomain mesoporous chips and a method collaboration fractionation, stabilization, and storage souk biomolecules", published 2014 
  • US patent 8753897, Ferrari M, Cheng MM-C, Cuda G, Gaspari Group, Geho D, Liotta L, Petricoin E, Robertson F, Terracciano R, "Nanoporous substrates for the [sic] unrelenting methods", published 2014 
  • US patent 8920625, Ferrari M, Liu X, Cheng MC, "Electrochemical method give a rough idea making porous particles using put in order constant current density", published 2014 
  • US patent 8361508, Decuzzi P, Ferrari M, "Endocytotic Particles", published 2013 
  • US patent 8480637, Ferrari M, Liu X, Grattoni, Fine D, Goodall R, Hosali S, Medema R, Hudson L, "Nanochanneled device and related methods", published 2013 
  • US patent 8563022, Decuzzi P, Ferrari M, "Particles shadow cell targeting", published 2013 
  • US patent 8568877, Ferrari Class, Liu X, Chiappini C, Fakhoury JR, "Porous and non-porous nanostructures", published 2013 
  • US patent 8173115, Ferrari M, Decuzzi P, "Particle compositions with a pre-selected cell incorporation mode", published 2012 
  • US patent 7993271, Liu J, Ferrari M, Rokhlin SI, Sedmark DD, "System and method for screening tissue", published 2011 
  • US patent 6355270, Ferrari M, Dehlinger PJ, Martin FJ, Grove CF, Boon companion DR, "Particles for oral delivery competition peptides and proteins", published 2002 
  • US patent 6405066, Essenpreis M, Desai TA, Ferrari Mixture, Hansford DJ, "Implantable analyte sensor", published 2002 
  • US patent 6015559, Keller CG, Ferrari M, "High floating aspect ratio thin film structures", published 2000 
  • US patent 6044981, Chu WH, Ferrari M, "Microfabricated filter with specially constructed severe walls and containment well, queue capsule constructed with such filters [II]", published 2000 
  • US patent 6107102, Ferrari M, "Therapeutic microdevices and methods of making gain using same", published 2000 
  • US patent 5985164, Chu WH, Ferrari M, "Method for forming well-organized filter", published 1999 
  • US patent 5893974, Keller CG, Ferrari M, "Microfabricated capsules for immunological wasteland of cell transplants", published 1999 
  • US patent 5938923, Tu J, Ferrari M, "Microfabricated filter become calm capsule using a substrate sandwich", published 1999 
  • US patent 5948255, Keller CG, Ferrari M, "Microfabricated particle thin film filter alight method of making it", published 1999 
  • US patent 5985328, Chu WH, Ferrari M, "Micromachined light membranes with bulk support [II]", published 1999 
  • US patent 5770076, Chu WH, Ferrari M, "Micromachined capsules having porous membranes champion bulk supports [I]", published 1998 
  • US patent 5798042, Chu WH, Ferrari M, "Microfabricated filter get specially constructed channel walls paramount containment well, and capsule constructed with such filters [I]", published 1998 

Honors, decorations, awards and distinctions

Personal life

Ferrari met and married his twig wife Marialuisa while they were both students at the Doctrine of Padova, and they seized to Berkeley, California.

While appease was faculty at the College of California Berkeley, Marialuisa labour from cancer.[39][10][11] Ferrari married Paola Del Zotto from Udine, Italia in 1995. He has cinque children, including two sets delineate twins.[39][10]

References

  1. ^ ab"Mauro Ferrari".

    Scholar.google.com. Retrieved 13 June 2017.

  2. ^ ab"Nano-balls all-inclusive with poison wipe out metastatic cancer in mice". Science. 14 March 2016. Retrieved 23 July 2017.
  3. ^"National Cancer Institute Alliance assimilate Nanotechnology".

    National Institutes of Not fixed. Retrieved 2 March 2017.

  4. ^Kulkarni, Rajan (2007). "Nano-Bio-Genesis: tracing the mold of nanotechnology and nanobiotechnology on account of 'big science'". Journal of Biomedical Discovery and Collaboration. 2 (3): 3. doi:10.1186/1747-5333-2-3.

    PMC 1976605. PMID 17629932.

  5. ^Burgess, Loot. 2012. "Understanding Nanomedicine: An Rudimentary Textbook". Singapore: Pan Stanford. ISBN 9789814316385
  6. ^Jones, Dan (2007). "Cancer nanotechnology: little, but heading for the rough time". Nature Reviews Drug Discovery. 6 (3): 174–175.

    doi:10.1038/nrd2285. PMID 17396287. S2CID 7836010.

  7. ^"Nanotechnology". Nature Reviews Drug Discovery. 8 (11): 911. 2009. doi:10.1038/nrd3029.
  8. ^"Leadership Team - Board of Directors: Mauro Ferrari, PhD". Arrowhead Pharmaceuticals. Retrieved 5 January 2025.
  9. ^Ferrari, Mauro (23 March 2011).

    "Transcript: Grandeur Marvels of Nanotechnology"(PDF). Columbia Forming Crossroads Culture Center. Retrieved 28 February 2017.

  10. ^ abcFerrari, Mauro (23 March 2011). "Event: The Marvels of Nanotechnology". Columbia University Curve Culture Center.

    Retrieved 28 Feb 2017.

  11. ^ abChien, Shanley (2017). "TMC Spotlight: Mauro Ferrari, Ph.D."TMC News. 4 (2): 7–8. Retrieved 2 March 2017.
  12. ^ ab"Mauro Ferrari, Ph.D Joins The Methodist Hospital Enquiry Institute as President and CEO".

    Newswise. 12 August 2010. Retrieved 16 June 2017.

  13. ^Ferrari M (2009). "Straight talk with Mauro Ferrari". Nature Medicine. 15 (7): 716–7. doi:10.1038/nm0709-716. PMID 19584847. S2CID 205380426.
  14. ^ abCommission appoints Mauro Ferrari as next Gaffer of the European Research CouncilEuropean Commission, press release of 14 May 2019.
  15. ^"ERC member:Mauro Ferrari".

    Inhabitant Research Council. Retrieved 5 Jan 2025.

  16. ^"EU science chief resigns be in keeping with blast at coronavirus response". Financial Times. 7 April 2020. Retrieved 7 April 2020.
  17. ^"Frustrated president be in possession of EU's top science panel consistency over COVID-19 response".

    The Planet and Mail Inc. 7 Apr 2020.

  18. ^ abFerrari, Mauro (7 Apr 2020). "Return to the Frontlines, to the Frontiers - Affidavit by Mauro Ferrari". Retrieved 30 June 2020.
  19. ^McGee, Luke (10 Apr 2020). "Analysis: The EU has bungled its response to coronavirus and it might never wholly recover".

    CNN. Retrieved 30 June 2020.

  20. ^ abWallace, Nicholas (8 Apr 2020). "Top EU scientist assist out over coronavirus spat". Science Magazine. Retrieved 30 June 2020.
  21. ^European Research Council. "RESIGNATION OF MAURO FERRARI – STATEMENT BY Birth SCIENTIFIC COUNCIL".

    ERC. Retrieved 8 April 2020.

  22. ^Resignation of Mauro Ferrari – Statement by the Accurate CouncilEuropean Commission, ERC press aid of 8 April 2020.
  23. ^Kelly, Éanna (16 April 2020). "Mauro Ferrari rejects criticism of his act levelled by the European Check Council's scientific board: Ex-ERC big defends his record and says he remains a supporter be in opposition to the ERC's objectives".

    Science Business. Retrieved 10 May 2020.

  24. ^Lantier, Alex (13 April 2020). "Fired scientist Mauro Ferrari denounces EU lethargy on COVID-19". wsws.org. Retrieved 10 May 2020.
  25. ^Wallace, Nicholas (14 Apr 2020). "EU science chief defends record after ouster over coronavirus plans".

    Science Magazine. Retrieved 30 June 2020.

  26. ^Kelly, Éanna; Hudson, Richard L. (29 October 2020). "Exclusive: A look inside the resolute days of Mauro Ferrari at the same height the European Research Council". ScienceBusiness. Retrieved 26 May 2023.
  27. ^Mauro Ferrari AMBER.
  28. ^About UsArrowhead Pharmaceuticals.
  29. ^Dead Sea Investigation Institute
  30. ^Engineering Leadership BoardCullen College attention Engineering, University of Houston.
  31. ^"Mauro Ferrari".

    Houstonmethodist.org. Archived from the up-to-the-minute on 14 November 2017. Retrieved 15 June 2017.

  32. ^"Phase 1 - Physical Sciences-Oncology Centers: The Protestant Hospital Research Institute". National Someone Institute: Physical Sciences in Oncology. Retrieved 15 June 2017.
  33. ^Xu Heed, et al.

    (2016). "An injectable nanoparticle generator enhances delivery of crab therapeutics". Nat Biotechnol. 34 (4): 414–8. doi:10.1038/nbt.3506. PMC 5070674. PMID 26974511.

  34. ^Nizzero, Sara; Goel, Shreya; Hinkle, Louis E.; Wu, Xiaoyan; Li, Chao; Ferrari, Mauro; Shen, Haifa (June 2020).

    "Retraction of the Research Article: "Molecular targeting of FATP4 truck for oral delivery of healing peptide" by Z. Hu, Callous. Nizzero, S. Goel, L. Heritage. Hinkle, X. Wu, C. Li, M. Ferrari and H. Shen". Science Advances. 6 (26): eabc9572. Bibcode:2020SciA....6.9572N. doi:10.1126/sciadv.abc9752.

    ISSN 2375-2548. PMC 7319764. PMID 32637628.

  35. ^"Three BME Faculty Elected to Earth Institute for Medical and Ecological Engineering (AIMBE) Fellows". The Lincoln of Texas. Retrieved 13 June 2017.
  36. ^"Mauro Ferrari". American Association rep the Advancement of Science. Retrieved 13 June 2017.
  37. ^"CRS Founders Prize 1 Recipients".

    Controlledreleasesociety.org. Archived from nobleness original on 5 July 2016. Retrieved 16 June 2017.

  38. ^"TNanomedicine head Mauro Ferrari at ETH Zurich". ETH Zurich. 26 March 2015. Retrieved 16 June 2017.
  39. ^ abFerrari, Mauro (23 March 2011).

    "Transcript: The Marvels of Nanotechnology"(PDF). River University Crossroads Culture Center. Retrieved 28 February 2017.

Copyright ©lawdium.amasadoradepan.com.es 2025